Article info

Download PDFPDF
Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo
  1. Correspondence to:
 Dr J Ilan, Department of Reproductive Biology, Case Western Reserve University, University MacDonald Women's Hospital, 11100 Euclid Avenue, Cleveland, OH 44106–4943, USA;
 cheryl.chernicky{at}uhhs.com
View Full Text

Citation

Chernicky CL, Tan H, Yi L, et al
Treatment of murine breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor decreases the level of plasminogen activator transcripts, inhibits cell growth in vitro, and reduces tumorigenesis in vivo

Publication history

  • First published April 1, 2002.
Online issue publication 
June 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.